Previous studies from our research group demonstrate that G6PD could promote ccRCC cell proliferation and invasion through upregulating the expression of CyclinD1 and MMP2, respectively 9, 12. This evidence concerns the gene MMP2 and nonpapillary renal cell carcinoma.